
Anthony Sinskey, CBI MIT |

Jackie Wolfrum, CBI MIT |

Bruce Levine,
University of Pennsylvania |

David Williams,
Loughborough University |

Knut Niss, Biogen |

(l-r) Dan Gold, BioMarin and
Annie Wang, Northeastern University |

(l-r) Mark Moody, Immunova and
Karen Yuan Mei, MIT |

Brian Teague, MIT |

Chris Ballas, WuXi AppTec |

Michael Washabaugh, MedImmune |

Martha Rook, EMD Millipore |

Brian Hawkins, BioLife Solutions |

Gary C. du Moulin, Massachusetts College of Pharmacy and Health Sciences University |

Denise Gavin, US Food and Drug Administration |

John Duguid, Vericel Corporation |

Alison Wilson, CellData Services |

Bill Lundberg, CRISPR Therapeutics |

Panel Discussion (l-r) Gary C. du Moulin, Anne Plant, and Michael Paglia |

Panel Moderator:
Jackie Wolfrum, CBI MIT |

(l-r) Stacy Springs, CBI MIT,
Bill Hancock, Northeastern University and TIM the Beaver, MIT |